Progenics Pharmaceuticals Announces First Quarter 2016 Financial and Business Results

Go back to Progenics Pharmaceuticals Announces First Quarter 2016 Financial and Business Results

Progenics Pharma (PGNX) Misses Q1 EPS by 5c

May 5, 2016 9:38 AM EDT

Progenics Pharma (NASDAQ: PGNX) reported Q1 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.27 million.

For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.

... More